Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Clinical trial NCT00967993 · COMPLETED

Trial details

NCT number: NCT00967993
Sponsor: Keryx Biopharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Hyperphosphatemia End-stage Renal Disease Renal Failure Chronic Requiring Hemodialysis

Start date: 2010-01-01
Primary completion: 2010-05-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.